Older diabetes treatment appears to have anti-dementia effect
Researchers report a link between use of glitazones to treat type 2 diabetes and a 22% reduced risk of dementia. The findings appeared on Oct 11, 2022 in BMJ Open Diabetes Research & Care. “These findings may help inform medication selection for [older] patients with [type 2 diabetes] at high risk of dementia,” the authors said. As background, the authors noted […]
Recent Comments